Health & Wellbeing

Keratoconjunctivitis Sicca in Dogs: Symptoms, Treatment & Care Guide

Complete guide to keratoconjunctivitis sicca in dogs — symptoms, diagnosis, treatment costs, prognosis, and daily management tips for canine dry eye.

By Robin Maitland · Published 10 September 2026
Keratoconjunctivitis Sicca in Dogs: Symptoms, Treatment & Care Guide

If your dog's eyes look persistently dry, red, or coated in thick mucus, you may be dealing with one of the most common canine ophthalmic conditions: keratoconjunctivitis sicca (KCS), widely known as dry eye. This condition occurs when the lacrimal (tear) glands fail to produce enough of the aqueous (watery) layer of the tear film, leaving the cornea and conjunctiva unprotected, irritated, and vulnerable to ulceration and infection.

KCS affects an estimated 1% to 4% of the general dog population, though certain breeds see prevalence rates exceeding 20%. It can be immune-mediated (the most common form, where the body's own immune system attacks the tear glands), congenital, drug-induced, neurogenic, or secondary to systemic diseases like canine distemper or hypothyroidism. Left untreated, keratoconjunctivitis sicca in dogs progressively damages the cornea and can lead to permanent blindness.

The good news? With early diagnosis and consistent treatment, most dogs with KCS maintain good vision and quality of life. This guide walks you through everything you need to know — from recognizing early symptoms to understanding treatment costs and long-term management.

What Is Keratoconjunctivitis Sicca in Dogs?

Keratoconjunctivitis sicca (KCS) is a medical condition characterized by deficient tear production. A healthy canine tear film has three layers:

  • Lipid (oily) layer — produced by the meibomian glands, prevents evaporation
  • Aqueous (watery) layer — produced by the lacrimal gland and gland of the third eyelid, provides moisture, oxygen, and nutrients to the cornea
  • Mucin layer — produced by conjunctival goblet cells, helps the tear film adhere to the corneal surface

In most KCS cases, it's the aqueous layer that's deficient. Without adequate watery tears, the remaining mucin and oils create a thick, ropey discharge that clings to the eye surface. The cornea, deprived of oxygen and lubrication, begins to undergo pathological changes — pigment deposition, vascularization (new blood vessel growth), and eventually scarring that obstructs vision.

According to the Merck Veterinary Manual, immune-mediated adenitis (destruction of the lacrimal gland tissue by the immune system) accounts for the majority of KCS cases in dogs. The exact trigger for this immune attack isn't fully understood, but a genetic predisposition is strongly suspected.

Key distinction: KCS is not the same as "dry eye" caused by environmental irritants or temporary dehydration. True KCS involves measurable, chronic tear deficiency that requires medical management — it will not resolve on its own.

Recognizing the Symptoms: From Early Warning Signs to Advanced Disease

KCS symptoms typically develop gradually, and early signs are easy to mistake for minor irritation or allergies. Here's how the symptoms progress:

KCS Symptom Checklist by Severity
Stage Symptoms What's Happening
Early (Mild)
  • Occasional redness of the conjunctiva
  • Slightly increased blinking or squinting
  • Small amounts of thick, yellow-green mucus in the inner corner of the eye
  • Dull or lackluster appearance to the cornea (normally should look wet and glossy)
Tear production is declining. The eye is beginning to compensate but isn't yet critically dry. Many owners dismiss this as "sleep" or mild allergies.
Moderate
  • Persistent, thick mucoid or mucopurulent discharge coating the eye
  • Noticeable redness and inflammation of the conjunctiva (conjunctivitis)
  • Frequent pawing at or rubbing the eye
  • Cornea begins to look hazy or cloudy
  • Recurrent eye infections
Corneal surface is becoming damaged. Bacterial overgrowth is common because tears normally flush bacteria away. Pigment may begin depositing on the cornea.
Advanced (Severe)
  • Corneal pigmentation (brown/black patches covering the cornea)
  • Corneal vascularization (visible red blood vessels growing across the cornea)
  • Corneal ulceration (painful open sores on the eye surface)
  • Significant vision impairment or blindness
  • Eye appears persistently dry, sunken, or shrunken
  • Pain behaviors: keeping eye closed, head shyness, decreased activity
Structural damage to the cornea is occurring. Without aggressive treatment, scarring becomes permanent and vision loss may be irreversible. In end-stage disease, the eye may require surgical removal.
Important: If your dog is squinting one or both eyes shut, has a visible blue-white haze over the cornea, or shows sudden behavioral changes like bumping into furniture, these are urgent signs that require veterinary evaluation within 24 hours. Corneal ulcers can progress rapidly and lead to eye perforation.

Breeds at Risk and Other Predisposing Factors

Risk Factors for Keratoconjunctivitis Sicca in Dogs

High-risk breeds (prevalence significantly above general population):

  • English Cocker Spaniel — highest reported breed prevalence, estimated at up to 20% in some populations
  • West Highland White Terrier
  • Cavalier King Charles Spaniel
  • English Bulldog
  • Lhasa Apso
  • Shih Tzu
  • Pug
  • American Cocker Spaniel
  • Pekingese
  • Boston Terrier
  • Samoyed
  • Yorkshire Terrier

Other risk factors:

  • Age: Most commonly diagnosed in middle-aged to older dogs (6-10 years), though congenital KCS can appear in puppies
  • Sex: Some studies show a slight female predisposition, though findings vary
  • Medications: Sulfonamide antibiotics (e.g., sulfasalazine, sulfadiazine) can cause drug-induced KCS, sometimes irreversibly
  • Systemic disease: Hypothyroidism, canine distemper virus, leishmaniasis, and diabetes mellitus are associated with secondary KCS
  • Previous surgery: Cherry eye removal (excision of the gland of the third eyelid rather than replacement) was historically a common cause — the third eyelid gland produces 30-50% of the aqueous tear layer
  • Radiation therapy: Treatment near the eye can damage lacrimal tissue
  • Neurological damage: Facial nerve (CN VII) paralysis or trigeminal nerve (CN V) damage can cause neurogenic KCS

Brachycephalic breeds (Pugs, Bulldogs, Shih Tzus) face a compounding risk: their prominent eyes have greater corneal exposure and often have incomplete blink coverage (lagophthalmos), meaning even a mild tear deficiency causes more severe corneal damage than it would in a dog with deeper-set eyes.

How Is Keratoconjunctivitis Sicca Diagnosed?

Diagnosing KCS is straightforward for a veterinarian and involves a combination of quick in-office tests. Here's what to expect during the diagnostic process:

Diagnostic Process Flowchart

  1. Step 1: Complete Ophthalmic Exam — Your vet examines the eyelids, conjunctiva, cornea, and anterior chamber. They check for discharge character, corneal clarity, and signs of ulceration. (Included in exam fee: $55–$95)
  2. Step 2: Schirmer Tear Test (STT) — A standardized strip of filter paper is placed in the lower conjunctival sac for exactly 60 seconds. The strip wicks up tears, and the wetting length is measured in millimeters.
    • Normal: ≥15 mm/min
    • Borderline/early KCS: 10–14 mm/min
    • Definitive KCS: <10 mm/min
    • Severe KCS: <5 mm/min
    (Cost: $25–$50, often bundled with exam)
  3. Step 3: Fluorescein Stain — A green-orange dye is applied to the cornea to check for ulcers or abrasions. This is critical because KCS-related ulcers change the treatment plan (some medications are contraindicated with active ulcers). (Cost: $20–$40)
  4. Step 4: Tonometry (optional) — Measures intraocular pressure to rule out concurrent glaucoma. (Cost: $30–$60)
  5. Step 5: Additional Testing (if indicated) — If an underlying systemic cause is suspected:
    • Thyroid panel (T4, free T4, TSH): $80–$180
    • Complete blood count and chemistry panel: $120–$250
    • Infectious disease titers (distemper, leishmaniasis): $50–$150 per test

Total diagnostic cost range: For uncomplicated KCS (STT + fluorescein stain + exam), expect to pay $100–$200 at a general practice. If your vet refers you to a veterinary ophthalmologist for specialized evaluation, the consultation alone typically runs $200–$400, with additional testing on top.

One important note: the Schirmer tear test should ideally be performed before other manipulations of the eye (like fluorescein staining or eyelid retraction for examination), because stimulating the eye can cause reflex tearing that falsely elevates the reading. A good veterinary team will run the STT first.

Treatment Options: Medical, Surgical, and Supportive Care

KCS treatment depends on severity, underlying cause, and response to therapy. Most dogs require lifelong management. Here's a comparison of the primary treatment approaches:

KCS Treatment Comparison
Treatment Type Mechanism Success Rate / Notes Typical Monthly Cost
Cyclosporine ophthalmic (Optimmune® 0.2%, compounded 1-2%) Medical — first-line Immunomodulator that suppresses the immune attack on lacrimal glands, allowing tear production to recover Effective in ~70-80% of immune-mediated cases; may take 4-8 weeks to see full effect. Less effective when STT is <2 mm/min at diagnosis (extensive gland destruction) $25–$65 (Optimmune); $15–$40 (compounded)
Tacrolimus ophthalmic (compounded 0.02-0.03%) Medical — second-line or adjunct More potent immunomodulator than cyclosporine; used when cyclosporine alone is insufficient Effective in many cyclosporine-resistant cases; often combined with cyclosporine. Requires compounding pharmacy $30–$60
Artificial tear supplements (GenTeal®, Systane®, Refresh®) Supportive Provides temporary lubrication to protect the corneal surface Essential adjunct therapy but does NOT treat the underlying cause. Must be applied 3-6x daily. Does not restore natural tear production $8–$20
Pilocarpine (oral or topical) Medical — neurogenic KCS Cholinergic stimulant that triggers tear gland secretion via nerve stimulation Effective primarily for neurogenic KCS (nerve damage). Narrow therapeutic index — overdose causes salivation, vomiting, diarrhea, bradycardia. Dosing must be carefully titrated by your vet $15–$35
Topical antibiotics Medical — secondary infection Treats bacterial overgrowth secondary to inadequate tear flushing Short-term use during flare-ups or initial treatment phase. Not a standalone KCS treatment $15–$30 per course
Topical corticosteroids Medical — anti-inflammatory Reduces corneal inflammation and pigment deposition Used cautiously and only AFTER corneal ulceration is ruled out via fluorescein stain. Steroids + corneal ulcer = risk of perforation. Your vet will determine if/when steroids are safe $15–$35
Parotid duct transposition (PDT) Surgical Reroutes the parotid (salivary) duct to the eye, using saliva as a tear substitute Reserved for cases unresponsive to all medical therapy. Success rate ~70-80% for maintaining corneal moisture. Complications include salivary mineral deposits on the cornea, facial dermatitis from constant moisture, and duct obstruction. Requires a veterinary ophthalmologist $1,500–$3,500 (one-time surgical cost)
Partial tarsorrhaphy Surgical — supportive Partially sutures the eyelids together to reduce corneal exposure and tear evaporation Used as a temporary or adjunct measure, particularly in brachycephalic breeds with severe exposure keratitis $500–$1,200

What a Typical Treatment Protocol Looks Like

For a newly diagnosed dog with moderate immune-mediated KCS, a standard initial protocol might include:

  1. Cyclosporine 0.2% ointment (Optimmune) — applied to both eyes twice daily, approximately 12 hours apart. A thin ribbon (~1/4 inch) is placed along the lower eyelid margin.
  2. Artificial tear gel or drops — applied 3-4x daily, timed between cyclosporine applications (wait at least 5 minutes between different medications).
  3. Warm compress and gentle cleaning — once or twice daily to remove accumulated mucus before medication application (medications don't penetrate well through a mucus barrier).
  4. Recheck Schirmer tear test — scheduled at 4 weeks, then 8 weeks, then every 3-6 months once stable.

Many dogs show measurable improvement in tear production within 4-6 weeks of starting cyclosporine. If there's no improvement at the 6-8 week mark, your vet may increase the cyclosporine concentration (via compounding pharmacy to 1% or 2%), add tacrolimus, or investigate an alternative underlying cause.

Never stop treatment without veterinary guidance. KCS is a chronic condition that typically requires lifelong medication. Even when tear production normalizes on the Schirmer test, stopping cyclosporine will usually result in relapse within weeks to months. Some dogs can be maintained on reduced frequency (once daily instead of twice), but this must be guided by repeat STT monitoring.

Prognosis and Life Expectancy

KCS itself is not life-threatening — it does not shorten a dog's lifespan. However, it can dramatically affect quality of life through pain, chronic discomfort, and vision loss if inadequately managed. Here's how prognosis breaks down by severity:

Prognosis by Disease Stage
Stage at Diagnosis STT Reading Expected Outcome with Treatment Vision Outlook
Early/Mild 10–14 mm/min Excellent. Tear production often normalizes fully with cyclosporine. Minimal corneal changes. Pigment and vascularization typically regress over months. Full vision preservation expected in >95% of cases
Moderate 5–9 mm/min Good to excellent. Most dogs respond well to cyclosporine ± tacrolimus. Some corneal pigment may persist but often doesn't significantly impair vision. Good vision preservation in ~85-90% of cases with consistent treatment
Severe <5 mm/min Guarded to fair. Extensive gland destruction may limit response to immunomodulators. May require higher concentrations, combination therapy, or surgical intervention. Corneal scarring may be partially permanent. Variable — depends on degree of existing corneal damage. Some dogs maintain functional vision; others have significant impairment. With aggressive treatment, many still have acceptable quality of life
End-stage (untreated) 0–2 mm/min with dense corneal pigmentation Poor for vision restoration. Dense pigment and scarring may be irreversible. Surgical options (PDT) can improve comfort but won't restore lost vision. Enucleation (eye removal) may be recommended if the eye is chronically painful. Significant vision loss likely. Dog adapts well to blindness in a stable home environment

The single most important prognostic factor is how early the disease is caught. Dogs diagnosed and treated at the mild stage almost always maintain normal vision and require only straightforward medication management. This is why routine veterinary wellness exams — where the vet can observe subtle eye changes — are so valuable for at-risk breeds.

Home Care, Daily Management, and Monitoring

Living with a KCS dog means establishing a consistent daily eye care routine. Here's what that looks like in practice:

Daily Care Checklist

  • Morning medication application: Gently wipe away any overnight mucus accumulation with a warm, damp, lint-free cloth or sterile eye wipe. Apply cyclosporine (or prescribed medication) to the lower eyelid margin. Wait 5+ minutes, then apply artificial tears if prescribed.
  • Midday artificial tears: Apply lubricating drops or gel, especially before outdoor activities or in dry/windy environments.
  • Evening medication application: Repeat the cleaning and medication process from the morning.
  • Before bed: Apply a thicker artificial tear gel or ointment for overnight corneal protection (tear production naturally decreases during sleep).

Environmental Adjustments

  • Use a humidifier in rooms where your dog spends the most time, especially during winter heating season when indoor humidity drops below 30%.
  • Avoid direct airflow from fans, car vents, or air conditioning hitting your dog's face — this accelerates tear evaporation.
  • Protect from wind and dust: Consider dog goggles (e.g., Doggles or Rex Specs) for car rides with windows down or outdoor activities in dusty/windy conditions.
  • Keep facial hair trimmed around the eyes in long-haired breeds to prevent hair from wicking tears away from the eye surface and to keep medication from being absorbed into fur instead of reaching the eye.

Monitoring at Home

Keep a simple eye health log noting:

  • Amount and character of discharge (color, consistency, volume)
  • Redness level (photos on the same lighting help track changes over time)
  • Comfort behaviors (squinting, pawing, rubbing)
  • Corneal clarity (does the eye look clear, hazy, or pigmented?)

Share this log with your veterinarian at recheck appointments — it helps them assess whether the current treatment protocol is adequate or needs adjustment.

Cost Breakdown: What to Budget for KCS Management

KCS is a chronic condition requiring lifelong treatment, so understanding the long-term financial commitment is important for planning.

KCS Cost Breakdown
Item Initial/One-Time Annual Ongoing
Veterinary exam + Schirmer tear test + fluorescein stain $100–$200 $100–$200 (1-2 rechecks/year)
Cyclosporine (Optimmune or compounded) — $200–$500
Tacrolimus (if needed) — $350–$700
Artificial tears/gels — $100–$240
Topical antibiotics (occasional courses) — $30–$120 (1-4 courses/year)
Veterinary ophthalmologist consultation (if referred) $200–$400 $200–$400 (if ongoing specialist care)
Parotid duct transposition surgery (if needed) $1,500–$3,500 Follow-up visits $100–$200
Enucleation — eye removal (worst case) $800–$2,500 —

Typical annual cost for medically managed KCS: $400–$900 per year for a dog responding well to cyclosporine alone, up to $1,200–$1,800 per year for dogs requiring combination therapy (cyclosporine + tacrolimus + frequent artificial tears).

First-year total (including diagnosis): $500–$1,200 for straightforward cases; $2,500–$5,000+ if surgical intervention is required.

If you have pet insurance, check your policy — most comprehensive plans cover KCS diagnosis and treatment as long as the condition wasn't present before the policy's effective date (pre-existing condition exclusion). Since KCS is relatively common and treatment is ongoing, this is one condition where insurance can provide meaningful financial relief.

Prevention Strategies

Because the most common form of KCS is immune-mediated with a strong genetic component, there is no guaranteed way to prevent it. However, you can take steps to reduce risk and catch it early:

  • Responsible breeding: If you're acquiring a puppy from a breed with known KCS predisposition, ask the breeder whether KCS has been documented in their breeding lines. The AKC and breed-specific health registries (like the OFA) may have health screening data.
  • Preserve the third eyelid gland: If your dog develops a "cherry eye" (prolapsed gland of the third eyelid), insist on surgical replacement (gland tacking) rather than excision (removal). Gland removal significantly increases KCS risk later in life. Modern veterinary ophthalmology considers gland removal an outdated approach except in rare circumstances.
  • Avoid sulfonamide drugs when alternatives exist: If your dog is prescribed a sulfa-class medication (e.g., for colitis or urinary infections), discuss KCS risk with your veterinarian and ask whether a non-sulfa alternative is appropriate.
  • Routine wellness exams: Annual (or biannual for senior dogs) veterinary exams should include basic eye assessment. Request a Schirmer tear test if you notice any of the early symptoms listed above, especially in a predisposed breed.
  • Manage systemic conditions: Keeping conditions like hypothyroidism well-controlled may reduce secondary KCS risk.

When to See the Vet Immediately

🚨 Red Flag Symptoms — Seek Veterinary Care Within 24 Hours

  • Eye held partially or fully closed (blepharospasm) — indicates significant pain, possibly from a corneal ulcer
  • Sudden blue-white cloudiness over the cornea — could indicate corneal edema, ulceration, or glaucoma
  • Visible indentation, divot, or color change on the corneal surface — may indicate a deep ulcer or descemetocele (emergency risk of eye perforation)
  • Sudden vision changes — bumping into objects, difficulty navigating familiar spaces, dilated pupil that doesn't constrict in bright light
  • Blood visible in or around the eye
  • Rapidly worsening discharge — especially if it becomes green, bloody, or foul-smelling
  • Eye appears to be bulging or the third eyelid is protruding abnormally
  • Systemic signs accompanying eye symptoms — lethargy, loss of appetite, fever, or facial swelling

If your dog is already diagnosed with KCS and on treatment: Contact your vet if tear production seems to be declining again (increased discharge, renewed redness, dull corneal appearance). The treatment protocol may need adjustment — medication concentrations may need to be increased, or a secondary condition may have developed.

Always consult your veterinarian before making any changes to your dog's medication regimen, and never use leftover human eye drops or unprescribed veterinary ophthalmic medications — some contain ingredients (like certain steroids) that can cause catastrophic corneal damage if an ulcer is present.

Frequently Asked Questions

Can keratoconjunctivitis sicca be cured in dogs?

In most cases, KCS cannot be "cured" in the sense of permanently eliminating the need for treatment. It is a chronic condition that typically requires lifelong medication. However, it can be very effectively managed — many dogs on consistent cyclosporine therapy have their tear production return to normal or near-normal levels on the Schirmer tear test and live comfortably without ongoing symptoms. Drug-induced KCS (e.g., from sulfa drugs) may partially or fully resolve after the offending drug is discontinued, depending on how much irreversible gland damage occurred.

Is KCS painful for dogs?

Yes. Imagine having sandpaper-dry eyes that you can't blink away — that's essentially what moderate-to-severe KCS feels like. Dogs with active KCS experience a gritty, burning sensation, and corneal ulcers (a common complication) are acutely painful. Dogs often express this pain through squinting, pawing at the eye, head shyness (flinching when you touch their head), and reduced willingness to play or exercise. Pain typically improves significantly within 1-2 weeks of starting appropriate treatment.

Can I use human artificial tears on my dog?

Basic, preservative-free artificial tear drops (like Refresh Plus or Systane Ultra) are generally safe for canine use as a supportive lubricant. However, avoid any products containing vasoconstrictors (like Visine/tetrahydrozoline — these are not safe for dogs) or products marketed for "redness relief." Always check with your veterinarian before using any over-the-counter product, and remember that artificial tears alone do not treat the underlying cause of KCS.

Will my dog go blind from KCS?

Blindness is a possible outcome of untreated or poorly managed KCS, but it is far from inevitable. With early diagnosis and consistent treatment, the vast majority of dogs maintain functional vision throughout their lives. The risk of blindness increases significantly when KCS is left untreated for months to years, allowing dense corneal pigmentation and scarring to develop. Even dogs with significant vision loss from KCS typically adapt well — dogs rely heavily on smell and hearing and often navigate their environment confidently even with limited sight.

How often should my dog with KCS see the veterinarian?

After initial diagnosis, expect recheck visits at 4 weeks, 8 weeks, and then every 3-6 months once the condition is stable. Each recheck should include a Schirmer tear test to objectively measure whether the current medication protocol is maintaining adequate tear production. If your dog is on topical corticosteroids, more frequent monitoring (including intraocular pressure checks) is needed to watch for steroid-related complications like glaucoma.

Which breeds are most prone to keratoconjunctivitis sicca?

The breeds with the highest documented predisposition include the English Cocker Spaniel (with some populations showing prevalence up to 20%), West Highland White Terrier, Cavalier King Charles Spaniel, English Bulldog, Lhasa Apso, Shih Tzu, Pug, American Cocker Spaniel, Pekingese, Boston Terrier, Samoyed, and Yorkshire Terrier. However, KCS can develop in any breed or mixed-breed dog, so vigilance is warranted regardless of breed.

Sources referenced: Merck Veterinary Manual — Keratoconjunctivitis Sicca in Small Animals; AKC — Dry Eye in Dogs; American Veterinary Medical Association (AVMA).

Written by

Robin Maitland

All our authors care for dogs every day — read more of their work on the authors page.